Pr→Pfr dark relaxation (as detected by Pfr absorbance) corresponding to the larger BphP1 concentrations (Fig. 1h) . The dark relaxation half-time was 900 s (Supplementary Table 1) , suggesting that the BphP1-PpsR2 binding substantially slowed the Pr→Pfr relaxation and BphP1-PpsR2 dissociation in darkness. After complete dark relaxation the complexes can be formed again by 740-nm light illumination (Fig. 1i) .
light-mediated control of protein-protein interactions to regulate cellular pathways is an important application of optogenetics. here, we report an optogenetic system based on the reversible light-induced binding between the bacterial phytochrome BphP1 and its natural partner Ppsr2 from Rhodopseudomonas palustris bacteria. We extensively characterized the BphP1-Ppsr2 interaction both in vitro and in mammalian cells and then used this interaction to translocate target proteins to specific cellular compartments, such as the plasma membrane and the nucleus. We showed light-inducible control of cell morphology that resulted in a substantial increase of the cell area. We demonstrated light-dependent gene expression with 40-fold contrast in cultured cells, 32-fold in subcutaneous mouse tissue, and 5.7-fold in deep tissues in mice. characteristics of the BphP1-Ppsr2 optogenetic system include its sensitivity to 740-to 780-nm near-infrared light, its ability to utilize an endogenous biliverdin chromophore in eukaryotes (including mammals), and its spectral compatibility with blue-light-driven optogenetic systems.
Spatiotemporal control of biochemical processes in cells and animals achieved through techniques such as optogenetics can help advance research in basic biology and biomedicine. An important avenue of optogenetic manipulation is the modulation of cellular protein-protein interactions (PPIs). Genetically encoded light-dependent systems exhibit several advantages over pharmacologically inducible PPI approaches because of their noninvasiveness, high PPI activation rates, reversibility, and lack of side effects potentially caused by drugs.
PPI optogenetic systems 1 were engineered from different photoreceptor families including LOV (light-oxygen-voltage) domain proteins 2, 3 , BLUF (blue light using FAD) domain proteins 4 , cryptochromes 5, 6 , and plant phytochromes [7] [8] [9] . The application of these optogenetic tools in mammals is complicated by their dependence on short-wavelength illumination outside of the near-infrared (NIR) tissue transparency window between 650 and 900 nm 10 . An exception is the phytochrome family, which is activated with far-red or NIR light. Phytochromes require the incorporation of tetrapyrrole chromophores. Phytochromobilin and phycocyanobilin serve as chromophores in plant phytochromes, A bacterial phytochrome-based optogenetic system controllable with near-infrared light Andrii A Kaberniuk, Anton A Shemetov & Vladislav V Verkhusha whereas bacterial phytochromes incorporate biliverdin IXα (BV) 11, 12 . Among these tetrapyrroles, BV exhibits the most NIRshifted absorbance spectra. While plant phytochrome-based optogenetic systems require an exogenous supply of phycocyanobilin 13 , the BV chromophore used by bacterial phytochromes is abundant in eukaryotic cells 14 . Therefore, bacterial phytochromes have been engineered into several types of NIR probes for mammalian tissues 15 , including constitutively fluorescent proteins 16, 17 , photoactivatable fluorescent proteins 18 , and PPI reporters 19 .
Bacterial phytochromes control gene expression and second messenger signaling in bacteria in response to NIR light 20 . These phytochromes consist of a photosensory core module and an output effector module. Natural output modules have been replaced with phosphodiesterase and adenylate cyclase, enabling the manipulation of cyclic nucleotides in mammalian cells [21] [22] [23] . Spectral properties of bacterial phytochromes are defined by a photosensory core module where the protein-chromophore interaction occurs 11, 24, 25 . Within the chromophore-binding pocket, BV can adopt two conformational states, Pr and Pfr, which absorb far-red and NIR light, respectively. Most bacterial phytochromes undergo photoconversion from the Pr state to the Pfr state when exposed to 660-to 700-nm light. However, there is a small group, termed 'bathy phytochromes' , that adopts Pfr as a ground state and undergoes Pfr→Pr photoconversion with 740-to 780-nm light 26 . Bacterial phytochromes can be converted back to a ground state either with light or through thermal relaxation in darkness.
The effector module of the bacterial bathy phytochrome RpBphP1 (BphP1) from R. palustris consists of two domains, PAS/ PAC (PAS domain with additional C-terminal residues) and HOS (2-helix output sensor), and has no detectable enzymatic activity. It has been proposed that BphP1 performs its signaling function by interacting with the transcriptional repressor RpPpsR2 upon NIR illumination 27 . While a light-induced BphP1-RpPpsR2 heterodimerization was observed by gel filtration, it was not characterized further 28 .
In this paper, we study the light-activatable interaction of BphP1 with RpPpsR2 in vitro and in vivo. We demonstrate recruitment of one of the interacting partners to specific cellular compartments and utilize this recruitment to induce intracellular signaling and to control gene expression. We show that the BphP1-RpPpsR2 pair can be used as a PPI-inducing NIR optogenetic system that is facilitated by the presence of endogenous BV in mammalian cells and animals.
results

Properties of purified BphP1
In its ground Pfr state, BphP1 absorbs maximally at 412 nm (Soret band) and at 756 nm (Q band) (Fig. 1a) . Upon NIR illumination, BphP1 photoconverts into the Pr state with absorbance at 390 nm and 678 nm for Soret and Q bands, respectively. We observed a 4.3-fold decrease in absorbance at 756 nm upon 740/25-nm irradiation (Supplementary Table 1 ). The highest light sensitivity of the Pfr state was observed at ~740-780 nm, with notable BphP1 photoconversion occurring at 800 nm (Fig. 1b) . Kinetics of the Pfr→Pr photoconversion was monoexponential ( Supplementary Fig. 1a) . The half-time of the Pfr→Pr transition was 28 s at 1 mW cm −2 , and it decreased to 3.5 s at 27 mW cm −2 (Fig. 1c) . After the Pfr→Pr photoconversion, BphP1 returned to the ground state in darkness with a half-time of 170 s. BphP1 could undergo repeated cycles of Pfr→Pr photoconversion followed by dark relaxation back to the Pfr state (Fig. 1d) . Irradiation with 636-nm light restored Pfr absorbance to ~80% (Fig. 1a) . The remaining ~20% of Pfr absorbance was restored during dark relaxation (Supplementary Fig. 1b) . The half-time of the Pfr→Pr conversion depended on the 636-nm light intensity, ranging from 21 s at 1 mW cm −2 to 3.0 s at 45 mW cm −2 (Fig. 1e) . Multiple cycles of photoswitching did not lead to notable changes in absorbance (Fig. 1f) .
BphP1-Ppsr2 interaction in vitro
RpPpsR2 has a single cysteine residue in position 439 and forms a noncovalent homodimer. To exclude the possibility of disulfide bond formation, we substituted cysteine 439 with serine and named this RpPpsR2-C439S variant PpsR2. We then fused mRuby2 to the C terminus of PpsR2 and characterized the BphP1-PpsR2 interaction using FRET. mRuby2 emission and BphP1 absorbance in the Pr state have good spectral overlap ( Supplementary Fig. 2a) , resulting in quenching of mRuby2 fluorescence (Supplementary Fig. 2b ). 740-nm light caused an increase in the Pr state, and the BphP1-PpsR2-mRuby2 binding caused up to a 12% decrease in mRuby2 fluorescence. A 27-fold change in 740-nm light intensity did not cause changes in the kinetics of the mRuby2 fluorescence decrease ( Supplementary  Fig. 2c ). For all intensities tested, the fluorescence quenching exhibited a half-time of ~60 s, which was larger than that observed for BphP1 alone (Fig. 1c) . This suggested that PpsR2 did not bind BphP1 in the Pfr state, and that the BphP1-PpsR2 interaction was not limited by the rate of Pfr→Pr photoconversion but rather by BphP1 and/or PpsR2 structural changes involved in the interaction.
Using 740 nm for the Pfr→Pr and 636 nm for the Pr→Pfr photoconversion, we monitored several cycles of FRET changes ( Fig. 1g) with half-times of ~60 s and ~30 s, respectively (Supplementary Table 1 ). The observed incomplete Pr→Pfr switching with 636-nm light could have been caused by overlap of the Pr and Pfr spectra at this wavelength (Fig. 1a) . Dark relaxation in the BphP1-PpsR2 complex was slower than photoswitching with 636 nm and depended on the BphP1:PpsR2 ratio, with shorter half-times of 
BphP1-Ppsr2 interaction in mammalian cells
To study the BphP1-PpsR2 interaction in mammalian cells we used a translocation assay (Fig. 2a) . We fused PpsR2 with mVenus and a CAAX plasma membrane localization signal, and we fused BphP1 with mCherry for cytoplasmic expression. Excitation of these fluorescent proteins did not photoconvert BphP1 (Supplementary Fig. 3 ). Illumination of HeLa cells with 740-nm light caused the translocation of BphP1-mCherry to the plasma membrane and a 25% decrease in mCherry cytoplasmic intensity after 3 min of 740-nm illumination detected with an epifluorescence microscope (Fig. 2b,c) . Subsequent dark incubation restored BphP1-mCherry fluorescence in the cytoplasm to the original level in ~24 min (Fig. 2b,d) . We demonstrated the reversibility of the BphP1 translocation to the plasma membrane and back to the cytoplasm for three cycles of 3 min of 740-nm illumination followed by 30 min of dark relaxation (Fig. 2e) , with the recovery of ~95% of the initial mCherry cytoplasmic intensity. Then we studied the effect of 650-nm light on acceleration of the BphP1 dissociation from the plasma membrane and found a 1.6-fold higher initial rate of BphP1-mCherry cytoplasmic signal recovery compared to the initial rate in darkness ( Supplementary  Fig. 4 ). However, complete dissociation of the BphP1-PpsR2 complexes required darkness. Illumination with 740-and 650-nm light for 3 min each resulted in ~8% reversible changes of the BphP1-mCherry cytoplasmic signal after the initial 25% decrease (Fig. 2f) , indicating that one-third of the BphP1-PpsR2 complexes could be modulated with light.
light-induced activation of a signaling pathway
We next used the BphP1-PpsR2 interaction for the recruitment of a DHPH domain of intersectin 1 (ref. 29) to the plasma membrane for activation of the small GTPase Cdc42 (refs. 30,31) . We fused the DHPH domain to the C terminus of BphP1-mCherry and coexpressed the construct in HeLa cells with PpsR2-mVenus-CAAX (Fig. 3a) . 740-nm illumination caused changes to cell morphology and a gradual increase of the cell area with a plateau after ~30 min (Fig. 3b) Fig. 7a,b) . The time course of SEAP production revealed an ~14-fold increase in SEAP after 12 h of 740-nm illumination compared to that in dark-treated cells (Supplementary Fig. 7c ). SEAP accumulation exhibited a half-time of ~18 h and reached a plateau after 48 h ( Fig. 4c and Supplementary Fig. 7c ). SEAP expression level depended on the power of activating light, with SEAP signal observed in cells irradiated with as little as 0.05 mW cm −2 ( Supplementary Fig. 8) . Similarly, the light-induced BhpP1−PpsP2 interaction that caused EGFP expression from a pTRE-Tight-EGFP reporter plasmid resulted in more than 27-fold greater EGFP signal in illuminated cells over dark-treated cells as detected by flow cytometry (Supplementary Fig. 9 ). We next studied how fast the light-induced transcriptional activation could be terminated. We illuminated cells with 740-nm light for 12 h and then kept them in darkness. The SEAP reporter production increased ~2.6-fold during the first 12 h in darkness (likely because of preaccumulation of SEAP mRNA) and subsequently decreased with a half-time of ~8 h (Fig. 4d) . We tested whether 636-nm light would accelerate the termination of transcriptional activation and found that 12 h illumination at 636 nm after the 12-h illumination period with 740-nm light decreased the SEAP production ~2.3-fold compared to the cells kept in darkness. Moreover, the SEAP decrease in the subsequent darkness after 636-nm illumination was also ~2-fold faster (Fig. 4d) . Thus, similar to cell membrane relocalization (Fig. 2) , mVenus-CAAX (Fig. 3c) . In the former cotransfection, the area increased up to 50% in some cells, with an average increase of ~25% (Fig. 3d) . The initial relative decrease of BphP1-mCherry-DHPH in the cytoplasm was two-fold higher than the cell area increase, indicating that BphP1-mCherry-DHPH translocated mainly during the first 5 min of 740-nm irradiation. Further changes were similar for mCherry fluorescence and cell area, suggesting that these changes were caused by an increase in the cell area ( Supplementary Fig. 5 ).
BphP1 recruitment to the cell nucleus
To examine whether we could optogenetically induce nuclear import, we transfected HeLa cells that stably expressed BphP1-mCherry with PpsR2-mVenus containing a nuclear localization signal (NLS). In darkness, NLS-PpsR2-mVenus localized to the nucleus, and BphP1-mCherry stayed in the cytoplasm (Fig. 4a) , with an mCherry intensity ratio between the nucleus and the cytoplasm of ~0.5 ( Supplementary Fig. 6 ). 740-nm illumination caused an increase of BphP1-mCherry fluorescence in the nucleus (Fig. 4a) , resulting in a nucleus:cytoplasm ratio of 1.8. Cells expressing only BphP1-mCherry displayed nucleus:cytoplasm ratios below 0.5, both in darkness and after illumination (Supplementary Fig. 6 ). Thus, the light-induced BphP1-PpsR2 interaction caused an ~3.5-fold increase of the BphP1-mCherry signal in nuclei of illuminated cells.
A light-inducible tetr-tetO transcription system
To develop a light-inducible transcription system, we combined the light-induced recruitment of BphP1 to the nucleus with a tetracycline-repressor-based system (Fig. 4b) We next compared two similar TetR-tetO transcription activation systems, one based on the BphP1-PpsR2 pair and another on a PhyB-PIF6 pair 13 , using the same reporter plasmid. The reporter expression was two-fold higher for the BphP1-PpsR2 than for the PhyB-PIF6 interaction (Supplementary Fig. 10 ). Comparison of light propagation for 660-and 740-nm wavelengths in various mammalian tissues revealed a substantially more effective penetration of NIR light (Supplementary Note and Supplementary  Fig. 11 ), resulting in higher reporter expression at greater tissue depth for the BphP1-PpsR2 system compared to the PhyB-PIF6 system (Supplementary Fig. 12 ).
light activation of gene expression in vivo
For activation of gene expression in vivo, we cotransfected stably expressing BphP1-mCherry-TetR HeLa cells with NLS-PpsR2-VP16 and pTRE-Tight-Rluc8 plasmids and subcutaneously injected the cells into the interscapulum area of FVB mice 24 h after cotransfection. Then, we either illuminated the animals with 740-nm light or kept them in darkness. After 48 h we detected a substantial increase of the Rluc8 signal in the illuminated mice (Fig. 5a ) as compared to those kept in darkness. The observed 32-fold activation contrast (Fig. 5b) was similar to that obtained in cell culture experiments (Supplementary Fig. 7b) .
We further compared the BphP1−PpsR2 system with a bluelight-activated LightON system 33 . In cultured cells, LightON activation with 470-nm light resulted in a 42-fold increase of the Rluc8 signal over the signal in dark-treated cells ( Supplementary  Fig. 13 ). However, experiments with subcutaneously injected cells in FVB mice led to only a 15-fold Rluc8 activation contrast (Fig. 5c,d) . This 2.8-fold drop in Rluc8 production in the LightON system was likely caused by the higher absorbance of 470-nm as compared to 740-nm light by ~1-mm-thick tissue.
To determine whether both the LightON and our system could potentially be used concurrently, we tested for optical crosstalk in cell culture. Activation of both systems in cultured cells with 470-nm and 740-nm light revealed their low crossactivation. We detected 12-fold higher activation of the LightON system with 470-nm light and 18-fold higher activation of the BphP1-PpsR2 system with 740-nm light (Supplementary Fig. 14) .
For deep tissue studies, we assessed the kinetics of light-induced Rluc8 expression in mice after hydrodynamic transfection (Fig. 5e-h and Supplementary Fig. 15 ). After 24 h we detected an increase of Rluc8 signal in livers of 740-nm-illuminated mice in comparison with the dark-treated animals (Fig. 5f) . After 48 h the Rluc8 signal reached its maximum with a 5.7-fold light-todark signal ratio (Fig. 5e,f) . Large differences of Rluc8 expression between the illuminated and dark-treated animals were observed up to 72 h after transfection (Fig. 5f) . To test the LightON system, we hydrodynamically transfected mice either with the large amounts of the LightON and reporter plasmids used in the original paper 33 ( Supplementary Fig. 15 ) or with amounts similar to those of the BphP1-PpsR2 system (Fig. 5g,h ). In the former case, after 470-nm illumination of mice for 24 h we observed a 1.7-fold increase of the Rluc8 production as compared to the dark-treated animals. In the latter case, the signal increase was 2.8-fold (Fig. 5g,h) , which was one-half of that detected for the BphP1-PpsR2 system (Fig. 5e,f) . The Rluc8 'bell-shaped' kinetics of the LightON activation in liver observed in both conditions was similar to that reported 34 . 
discussion
We have developed a novel optogenetic system based on the light-inducible interaction of bacterial phytochrome BphP1 and its binding partner PpsR2 from R. palustris. This system takes advantage of the high sensitivity of bacterial phytochromes to NIR light and their unique ability to incorporate heme-derived BV as a chromophore. The BphP1-PpsR2 optogenetic system can be used to activate several types of cellular processes. We showed the light-induced recruitment of cytoplasmic BphP1 to membrane-bound PpsR2 and used this approach to activate the Cdc42 signaling pathway. We extended the light-induced targeting approach to the recruitment of BphP1 to a nucleus and developed the transcription activation system. The light-induced transcription was reversible in darkness, while far-red illumination accelerated the transcription termination two-fold, allowing its more precise control. The implementation of our optogenetic tool as an NIR-light-inducible transcription system should enable protein expression in a spatiotemporally controlled manner in other model organisms that are compatible with the TetR-tetO (ref. 35) interaction. This light-inducible, tetracycline-independent, TetR-based system will allow researchers to avoid potential drawbacks associated with tetracycline consumption by experimental animals 36 .
For in vivo applications, optogenetic systems sensing NIR light are preferable because of their deep tissue penetration and low phototoxicity. The majority of far-red optogenetic systems are based on a PPI between plant phytochrome PhyB and the PIF6 factor 8, 13, 37 . They are activated with far-red light peaked at 660 nm, whereas BphP1-PpsR2 interaction is activated with NIR 740-to 780-nm light (Fig. 1b) . Moreover, the use of the PhyB-PIF6 system is limited by the requirement either to supply an exogenous phycocyanobilin chromophore 11, 12 or to produce it by coexpressing several bacterial enzymes 38 , thereby affecting cellular metabolism.
Our in vivo comparison of transcription activation by the blue-light-driven LightON system and the NIR-light-activated BphP1−PpsR2 system revealed a higher efficiency of the latter system at light intensities of ≤5 mW cm −2 , which are compliant with safety regulations 39 . These light intensities caused a smaller increase of the Rluc8 signal in a deep-seated liver in the 470-nm-illuminated animals as compared with the Rluc8 signal obtained with 90 mW cm −2 illumination used in the original LightON paper 33 .
In summary, we have characterized the BphP1-PpsR2 lightcontrollable PPI in vitro and in cells and animals, and we have demonstrated the use of this light-sensitive pair as an optogenetic system for subcellular protein targeting, induction of intracellular enzymatic activity, and activation of gene expression. The BphP1-PpsR2 system is orthogonal to mammalian cells and minimally interferes with their metabolism. Our results constitute a basis for the development of a new generation of optogenetic systems, which can be used either alone or in combination with blue-light npg optogenetic tools. Since we used practically unmodified BphP1 and PpsR2 proteins, we expect that the light sensitivity, kinetics, and reversibility of their interaction may be amenable to further optimization using molecular engineering approaches. 8 . An mRuby2 gene was PCR amplified from a pcDNA3-mRuby2 plasmid (Addgene #40260) 40 . A transactivation domain of transactivating tegument protein VP16 from Herpes simplex was PCR amplified from a pGV-2ER plasmid (Systasy). An Rluc8 gene encoding modified luciferase from Renilla reniformis was PCR amplified from a Nano-lantern/pcDNA3 plasmid (Addgene #51970). A SEAP gene was PCR amplified from a pKM611 plasmid kindly provided by W. Weber (University of Freiburg, Germany). A plasmid pKM022 encoding PhyB (1-650) was obtained by mutagenesis, using the pKM020 plasmid as a template 13 . A TetR gene (residues 1-207) that binds DNA in the absence of tetracycline/doxycycline was PCR amplified from a pTet-Off vector (Clontech).
The reporter plasmids pTRE-Tight-EGFP, pTRE-Tight-SEAP, and pTRE-Tight-Rluc8 were obtained by cloning the EGFP, SEAP, and Rluc8 genes, respectively, into a pTRE-Tight2 vector (Addgene #19407). The LightON system plasmids, pGAVPO (encoding GAL4(65)-VVD-p65 activation domain) and pU5-mCherry, were kindly provided by Y. Yang (East China University of Science and Technology, China) 33 . A pU5-Rluc8 reporter plasmid was generated by substitution of an mCherry gene in the pU5-mCherry plasmid with the Rluc8 gene. To develop stable preclonal cell mixtures of HeLa cells, plasmids encoding a transposase SB100X, pCMV(CAT)T7-SB100 (Addgene #34879), and transposon-bearing plasmids pT2/SVNeo and pT2/BH (Addgene #26553 and #26556) 41 were used. An IRESv10 with ~3-fold reduced expression strength 42 was obtained from IRES using mutagenesis.
For bacterial expression of the BphP1, BphP1-mRuby2, and PpsR2-mRuby2 proteins, vectors pBAD/His-D, pBAD/His-B (Life Technologies-Invitrogen), and pET22b (Novagen) were used, respectively. In the pET22b vector, an N-terminal pelB signal was replaced with a Strep-tag II.
Mammalian expression plasmids were based on either a pEGFP-N1 vector (Clontech), with either a standard CMV promoter or its truncated CMVd1 form, or on a pFC15K vector (Promega) with the truncated CMVd1 promoter.
The flexible linkers of 10 (-D-S-A-G-S-A-G-S-A-G-), 16 (-S-A-G-G-S-A-G-G-S-A-G-G-S-A-G-G-), 20 (-S-A-G-G-S-A-G-G-S-A-G-G-S-A-G-G-S-A-G-G-), or 24 (-S-G-G-G-S-G-G-G-S-G-G-G-S-G-G-G-S-G-G-G-S-G-G-G-) amino acids, a C-terminal membrane-localization CAAX signal from Kras4B (-K-K-K-K-K-K-S-K-T-K-C-V-I-M), a nuclear localization signal of nuclear cap-binding protein subunit 1 (MS-R-R-R-H-S-Y-E-N-D-G-G-Q-P-H-K-R-R-K-)
, and a Strep-tag II (-W-S-H-P-Q-F-E-K-) were added by oligonucleotide annealing. The designed plasmids are summarized in Supplementary Table 2.
Protein expression and purification. BphP1 and BphP1-mRuby2 proteins with polyhistidine tags on the N terminus were expressed in LMG194 bacterial cells (Life Technologies-Invitrogen) containing a pWA23h plasmid encoding heme oxygenase for biliverdin synthesis in Escherichia coli 18 . The bacterial cells were grown in RM medium supplemented with ampicillin, kanamycin, and 0.02% rhamnose for 6-8 h, followed by an induction of the protein expression by adding 0.002% arabinose. The proteins were purified using an Ni-NTA agarose (Qiagen). The PpsR2 and PpsR2-mVenus proteins with a Strep-tag II at the N terminus and a polyhistidine tag at the C terminus were expressed in BL21(DE3) bacterial cells grown in LB medium supplemented with ampicillin for 6 h, followed by an induction of a protein expression with 250 µM IPTG. The proteins were first purified with an Ni-NTA agarose (Qiagen) followed by purification with a Strep-Tactin sepharose (IBA Lifesciences).
In vitro characterizations of BphP1 properties. For absorbance measurements, a Hitachi U-2000 spectrophotometer was used. For fluorescence measurements of mRuby2 fusions, a FluoroMax-3 spectrofluorometer (Horiba-Jobin Yvon) was equipped with a 600-nm shortpass filter before detector was used. A photoconversion of BphP1 containing proteins was performed with 740/25-nm and 636/20-nm custom-assembled LED sources in quartz microcuvettes (Starna Cells). A determination of action spectrum was performed by measurement of the change in absorbance of Pfrstate BphP1 at 780 nm upon illumination with photoconversion light. The FluoroMax-3 spectrofluorometer was used as a light source. The illumination time was normalized to total amount of irradiated light energy, measured with a PM100 optical powermeter equipped with a S130A sensor (ThorLabs) at the respective wavelength. A half-time of Pr→Pfr transition (or dark relaxation) was measured by registering of absorbance at 780 nm after 5 min illumination of samples with 740/25 nm. Samples containing fixed quantities of BphP1 (5 µM) and various quantities of PpsR2 (0-5 µM) were preincubated in darkness for 30 min. Reversible dark relaxation cycles were obtained by the registration of 780-nm absorbance of protein mixture at BphP1:PpsR2 molar ratio of 8:1. To study changes in mRuby2 fluorescence due to FRET between the PpsR2-mRuby2 fusion and the Pr state of BphP1, the proteins (2.5 µM each) were preincubated in darkness for 30 min and then transferred to a microcuvette. An mRuby2 fluorescence intensity was registered every 30 s with excitation 545/2 nm and emission 585/10 nm. All spectroscopic measurements were performed at room temperature in PBS.
Mammalian cell culture. HeLa cells were purchased from the ATCC (CCL-2 line) and were not additionally authenticated or tested for mycoplasma contamination. The cells were grown in DMEM medium supplemented with 10% FBS, penicillin-streptomycin mixture, and 2 mM glutamine (all from Life TechnologiesInvitrogen) at 37 °C. For imaging, 10 5 cells were plated on 35-mm glass-bottom culture dishes (MatTek) precoated with ECL mixture (EMD-Millipore). Transient cell transfections were performed using an Effectene Transfection Reagent (Qiagen).
Preclonal mixtures of HeLa cells were obtained using the plasmid-based Sleeping Beauty transposon system. For this, sequences desired for genome integration were cloned into the transposonbearing plasmids pT2/BH or pT2/SVNeo and cotransfected with a plasmid encoding a hyperactive transposase SB100X. Cells were further selected with 700 µg/ml of G418 antibiotic for two weeks and enriched using a FACSAria sorter (BD Biosciences), resulting in the preclonal HeLa cell mixtures stably expressing BphP1-mCherry-TetR.
nAture methods
For light-induced relocalization to plasma membrane, HeLa cells were transiently cotransfected with pKA-140 or pKA-142 and pKA-141 plasmids in 1:1 ratio. For light-induced cytoskeletal rearrangement, cells were cotransfected with pKA-142 (or pKA-147) and pKA-144 plasmids in 1:2 ratio. The cell light activation and imaging were typically performed 48 h after the transfection. For light-induced nuclear relocalization, HeLa cells stably expressing BphP1-mCherry-TetR were transiently transfected with pCMV-160. To study light-induced transcription activation in the TetR-based system, HeLa cells stably expressing BphP1-mCherry-TetR were cotransfected with pCMV-104 and pTRE-Tight-EGFP, pTRE-Tight-SEAP or pTRE-Tight-Rluc8 plasmids in 5:1 ratio. To compare the PhyB-PIF6 system with the BphP1-PpsR2 system, HeLa cells were transfected with pKM022 and pTRE-Tight-SEAP plasmids in 2:1 ratio. All procedures after the transfection were performed as described in the PhyB-PIF6 paper 13 .
Cell light activation and imaging. Imaging was performed using an Olympus IX81 inverted epifluorescence microscope equipped with a 200-W metal halide arc lamp (Lumen 220PRO, Prior) and a 60×, 1.35 NA oil immersion objective lens (UPlanSApo, Olympus). During imaging HeLa cells were incubated in a cell imaging medium (Life Technologies-Invitrogen) and kept at 37 °C. Yellow (523/20-nm exciter and 565/40-nm emitter) and red (570/30-nm exciter and 615/30-nm emitter) channel filter sets (Chroma) were used for detection of mVenus and mCherry fluorescence, respectively. The Pfr→Pr photoconversion of BphP1 was done by illumination with 740/40-nm filters (Chroma).
For Pfr→Pr relocalization assay, HeLa cells were exposed to 740/40 nm and imaged every 15 s for 3 min. Intensity of activation light was 0.9 mW cm −2 . To quantify mCherry fluorescence in cell cytoplasm during BphP1 dark relaxation, HeLa cells were imaged every 3 min for 24 min, starting immediately after the Pfr→Pr photoconversion. Intensity profile of mCherry fluorescence through cell was determined using ImageJ v.1.46f software. Intensity of mCherry fluorescence in cytoplasm and nucleus was measured using SlideBook v.4.2.09.
To study light-induced cytoskeletal rearrangements, the Pfr→Pr photoconversion was done by illuminating cells using 740/40-nm filters for 3 min and imaging these cells every 15 s, followed by maintaining BphP1 in the Pr state by illuminating BphP1 with 740/40 nm for 15 s every minute and imaging BphP1 every 60 s. The intensity of activation light was 0.2 mW cm −2 . The total time of cell imaging was 30 min. The light power densities were measured at a back focal plane of a 60×, 1.35 NA objective lens. Membrane-localized mVenus was used for determination of cell area. The data were analyzed using ImageJ v.1.46f software.
Unless otherwise indicated, a light-induced transcription activation of HeLa cells was performed with a 740/25-nm LED source at 1.0 mW cm −2 using the 30 s On and 180 s Off cycle in a CO 2 incubator at 37 °C. Time of illumination varied in different experiments. For nuclear localization and EGFP or SEAP transcription activation experiments, cells were illuminated for 24 and 48 h, respectively. For kinetic studies of SEAP accumulation in culture media, three different illumination regimes were used: 72 h of 740/25 nm; 12 h of 740/25 nm followed by 60 h of darkness; and 12 h of 740/25 nm followed by 12 h of 636/20 nm followed by 38 h of darkness. To measure light sensitivity of SEAP expression activation, HeLa cells were irradiated with either 740/25-nm (with BphP1-PpsR2) or 660/20-nm (with PhyB-PIF6) light of various power densities (5-1000 µW cm −2 ). Light power densities and illumination durations were converted to photon counts.
Light-induced LightON transcription activation of Rluc8 in HeLa cells was performed as described in the original paper 33 . In brief, HeLa cells were transfected with pGAVPO and pU5-Rluc8 plasmids in 1:1 ratio. Then, cells were kept in darkness for 10 h. After change of culture medium, the cells were continuously illuminated with a 470/15-nm LED array (LuxeonStar) of 1 mW cm −2 , or the cells remained in darkness for 48 h before analysis. For analysis, the cells were resuspended in PBS and disrupted by freezing-thawing. An Rluc8 bioluminescence signal was measured in supernatants after the addition of 5 µM coelenterazine h (NanoLight Technology). A signal was detected using an IVIS Spectrum instrument (PerkinElmer/Caliper Life Sciences) and analyzed using Living Image 3.0 software (PerkinElmer/Caliper Life Sciences).
Flow cytometry analysis.
Flow cytometry analysis of lightinduced EGFP expression was performed 48 h after the HeLa cell transfection using a LSRII flow cytometer (BD Biosciences) equipped with a 488-nm laser and a 530/40-nm emission filter and with a 561-nm laser and 610/20-nm emission filter. To calculate an efficiency of the light-induced EGFP expression, a mean fluorescent intensity of EGFP-positive cells was multiplied by the number of positive cells, resulting in the total amount of synthesized proteins. Gates for counting EGFP-positive cells were set using nontransfected cells as a negative control. Typically, the cell samples were triplicated. Minimally, 5 × 10 4 cells were analyzed per sample. The data were analyzed using FACSDiva v. 6.1.3 and FlowJo v. 7.6.2 software.
Secreted alkaline phosphatase assay. For SEAP detection in culture media, a Great EscApe fluorescent SEAP Assay kit (Clontech) was used. 25-µl aliquots of cell culture media from wells of a 12-well plate were collected at each time point and stored at −20 °C. For kinetics studies, a culture medium was changed with a fresh medium at each time point. Fluorescence intensity of the SEAP reaction product was measured using the SpectraMax-M2 plate reader (Molecular Devices).
Light activation and imaging in mice. 2-to 3-month-old female FVB mice (National Cancer Institute, NIH) of 20-25 g body weight were used for in vivo comparison of the LightON and BphP1−PpsR2 systems. To compare the efficiency of the light-induced transcription activation, HeLa cells with either the LightON system or the BphP1−PpsR2 system were injected subcutaneously in the interscapular area of FVB mice. For better illumination, the fur on the backs of the mice was removed using a depilatory cream. For the LightON system, HeLa cells were cotransfected with the pGAVPO and pU5-Rluc8 plasmids in a 1:1 ratio; and for the BphP1−PpsR2 system, HeLa cells stably expressing BphP1-mCherry-TetR were cotransfected with the plasmid encoding NLS-PpsR2-VP16 and the pTRE-Tight-Rluc8 reporter plasmid in a 5:1 ratio. For both systems, the 3 × 10 6 HeLa cells in 100 µl of RPMI-1640 media supplemented with 2 mM L-glutamine were injected subcutaneously 24 h after the transfection. All manipulations with cells before and during the injection npg were performed under a 640-nm safelight for the LightON system and under a 530-nm safelight for the BphP1−PpsR2 system. After injection, mice were placed in transparent cages illuminated from the top with either the 470/15-nm LED array or the 740/25-nm LED array for the LightON and BphP1-PpsR2 systems, respectively. Intensities of 470/15-nm light and 740/25-nm light were the same and equal to 1 mW cm −2 . After injection, control mice were kept in darkness in conventional cages. Animals were either continuously illuminated or kept in darkness for 48 h, and they were released every 12 h and fed for 30 min. Each experimental group contained three mice.
For hydrodynamic transfection into liver 43 , the Swiss Webster 2-to 3-month-old female mice (National Cancer Institute, NIH) with body weights of 22-25 g were used. For the BphP1−PpsR2 system, 50 µg of the pKA-207I10 plasmid and 5 µg of the pTRETight-Rluc8 reporter plasmid in 2.5 ml of PBS were intravenously injected through a tail vein. For hydrodynamic transfection by the LightON system, we used the plasmid amounts either indicated in the original paper 33 (10 µg of the pGAVPO plasmid and 300 µg of the pU5-Rluc8 plasmid) or similar to those used for the BphP1-PpsR2 system (50 µg of the pGAVPO plasmid and 5 µg of the pU5-Rluc8 plasmid). The mice were placed in transparent cages and illuminated from the bottom with either the 470/15-nm LED array or the 740/25-nm LED array for the LightON and the BphP1-PpsR2 systems, respectively. Intensity of the activation light was the same and equal to 5 mW cm −2 . For better illumination and imaging, the belly fur was removed using a depilatory cream. Control animals were kept in conventional cages in complete darkness. Animals were continuously illuminated or kept in darkness for 72 h, and every 12 h they were released and fed for 30 min. Each experimental group contained three mice.
For bioluminescence detection, either 48 h after the HeLa cells injection or every 24 h after the hydrodynamic transfection of livers the animals were imaged using an IVIS Spectrum instrument (PerkinElmer/Caliper Life Sciences) in luminescence mode with an open emission filter. Throughout the imaging, animals were maintained under anesthesia with 1.5% vaporized isoflurane. Prior to imaging, 80 µg of Inject-A-Lume coelenterazine substrate for Rluc8 (NanoLight Technology) was intravenously injected through a retro-orbital vein. Data were analyzed using Living Image 3.0 software (Perkin Elmer/Caliper Life Sciences).
All animal experiments were performed in an AAALACapproved facility using protocols approved by the Albert Einstein College of Medicine Animal Usage Committee. 30 mice were used in this study. 
Supplementary Table 2.
Bacterial and mammalian plasmids designed in this paper. . The tissue optical properties are usually described in terms of three parameters: a scattering coefficient, μ s , an absorption coefficient, μ a , and a scattering anisotropy factor, g.
The absorption and scattering coefficients are defined as the probability of absorption or scattering, respectively, per a path-length unit. The third parameter is the scattering distribution in a turbid media, described by the anisotropy factor and obtained by computing the mean cosine of the scattering angle. The value of g, in a scale from −1 to 1, characterizes the direction of the scattering. In most biological tissue, the g value ranges from 0.70 to 0.99, indicating that photons are preferably scattered in the forward direction. Using g factor we can compute a reduced scattering coefficient, which takes into account the anisotropy of scattering in a studied tissue:
In a reality, when samples of a bulk tissue are analyzed, the above-mentioned parameters are difficult to evaluate, as these situations are characterized by the occurrence of multiple scattering and absorption events. As the consequence, to characterize optical properties of thick samples another parameter is utilized. An effective attenuation coefficient, μ eff , is equal to an inverse of the attenuation length at which the incident spatial irradiance is attenuated by factor of 1/e (~37%). The relation between μ eff , μ a and μ' s is defined as 3
The optical properties of different mammalian tissues have been studied by many research groups, and the µ a and μ' s coefficients were experimentally determined for many tissues [5] [6] [7] [8] [9] [10] .
Thus, it is possible to calculate μ eff using equation (2) .
Generally, a relation between absorbed light energy and pathway through which light travels is defined by Beer-Lambert law for thick layers:
where I 0 is the initial light intensity, μ eff is the effective attenuation coefficient of tissue at wavelength λ, and d is the path length of light through the sample.
Using equation (2) and (3) Fig.   14) . Substantial difference in penetration between 740 nm and 660 nm light at 1 cm depth is observed for the brain and muscle tissues where NIR light penetrates 4-fold more efficiently. The largest difference, ~11-fold, in penetration between 740 nm and 660 nm at 1 cm depth is observed for the breast tissue (Supplementary Fig. 14b ). This is because of the high level of fat and water content that resulted in the higher μ' s for 660 nm light.
Overall, our considerations are consistent with the results published earlier 11 .
Importantly, in the NIR tissue transparency window the depth of light penetration is highly affected by light-scattering phenomenon: the absorption coefficients for many tissues within 650-900 nm range are ~10-fold lower than the light-scattering coefficients 10 .
